Indication
Secondary Osteoporosis
2 clinical trials
4 products
Clinical trial
Efficacy of 4 mg Zoledronic Acid Plus Colaren vs 4mg Zoledronic Acid + Conventional Treatment for Secondary Osteoporosis in HIV Positive and Negative MenStatus: Completed, Estimated PCD: 2022-10-31
Product
ColarenProduct
Standard TreatmentClinical trial
The Efficacy of Denosumab to Prevent Bone Loss in Ambulatory and Non-ambulatory Motor-Incomplete Patients With Subacute Spinal Cord InjuryStatus: Terminated, Estimated PCD: 2021-12-31
Product
Denosumab